Dr. Levy on the Treatment of T790M-Mutant Lung Cancer

Benjamin P. Levy, MD, assistant professor of oncology, scientific director of medical oncology, Johns Hopkins Sidney Kimmel Most cancers Middle, Johns Hopkins Drugs, discusses the remedy choices for sufferers with T790M-mutant lung most cancers.In line with Levy, sufferers who progress on first- or second-generation tyrosine kinase inhibitors (TKIs) ought to be examined for T790M. T790M could be examined in blood and tissue however information counsel that the doctor ought to begin with a blood check.
If the affected person is constructive for T790M, osimertinib (Tagrisso) is accepted for the remedy of these sufferers, says Levy.

LEAVE A REPLY

Please enter your comment!
Please enter your name here